Inotuzumab ozogamicin
₹500.00
Inotuzumab ozogamicin is a medication used to treat a type of blood cancer called acute lymphoblastic leukemia (ALL). It is a type of targeted therapy that works by specifically targeting and destroying cancer cells while causing minimal damage to healthy cells in the body.
To understand how Inotuzumab ozogamicin works, let's break it down:
1. **What is Inotuzumab Ozogamicin?**
Inotuzumab ozogamicin is a combination of two components: a monoclonal antibody called inotuzumab and a chemotherapy drug called ozogamicin. The monoclonal antibody inotuzumab attaches to a protein called CD22, which is found on the surface of cancer cells in ALL. This allows the medication to specifically target and bind to the cancer cells.
2. **How Does it Work?**
Once inotuzumab attaches to the CD22 protein on the cancer cells, the chemotherapy drug ozogamicin is released into the cancer cell. Ozogamicin is a powerful toxin that damages the DNA inside the cancer cell, preventing it from growing and dividing. This ultimately leads to the death of the cancer cell.
3. **Targeted Therapy**
One of the advantages of Inotuzumab ozogamicin is that it is a targeted therapy. Unlike traditional chemotherapy drugs that can affect both cancerous and healthy cells, targeted therapies like Inotuzumab ozogamicin specifically target cancer cells, minimizing damage to healthy tissues and reducing side effects.
4. **Treatment for ALL**
Acute lymphoblastic leukemia (ALL) is a type of blood cancer that affects the white blood cells called lymphocytes. Inotuzumab ozogamicin is used to treat ALL in adults who have relapsed or refractory disease, meaning their cancer has come back after treatment or has not responded to previous treatments.
5. **Administration**
Inotuzumab ozogamicin is typically administered intravenously, meaning it is given directly into the bloodstream through a vein. It is usually given in cycles, with treatment given over a period of several weeks followed by a rest period to allow the body to recover.
6. **Side Effects**
Like all medications, Inotuzumab ozogamicin can cause side effects. Some common side effects may include nausea, fatigue, fever, headache, and low blood cell counts. More serious side effects may include liver problems, infusion-related reactions, and increased risk of infection.
7. **Monitoring and Support**
During treatment with Inotuzumab ozogamicin, patients are closely monitored by their healthcare team for any signs of side effects or complications. Supportive care, such as medications to manage side effects and regular blood tests to monitor blood cell counts, may be provided to help patients tolerate treatment.
In summary, Inotuzumab ozogamicin is a targeted therapy used to treat adults with relapsed or refractory acute lymphoblastic leukemia (ALL). By specifically targeting and destroying cancer cells while sparing healthy cells, it offers a promising treatment option for patients with this challenging disease. However, like all cancer treatments, it may cause side effects, and close monitoring and supportive care are essential for managing treatment-related complications.
Have any queries, book a consultation with our Oncology Clinical Specialist
Quantity
How does this medicine work
Inotuzumab ozogamicin is like a special arrow aimed at a specific target: cancer cells. Here's how it works:
1. **Finding the Target:** Imagine cancer cells as bad guys hiding in a crowd. Inotuzumab, the first part of the medication, acts like a detective, sniffing out a protein called CD22. This protein is like a name tag that only cancer cells wear.
2. **Taking Aim:** Once Inotuzumab finds CD22, it sticks to it, like a magnet locking onto metal. This is crucial because it ensures that the medication goes straight to the cancer cells and not to healthy cells.
3. **Delivering the Punch:** Now that Inotuzumab has guided the medication to the cancer cells, it's time for the second part, ozogamicin, to do its job. Ozogamicin is like a powerful punch packed into a tiny package. It gets released inside the cancer cells and damages their DNA, which is like their instruction manual for growth and survival.
4. **Stopping the Spread:** By damaging the DNA, ozogamicin stops the cancer cells from multiplying and eventually causes them to die. This helps to slow down or even stop the spread of cancer in the body.
In simple terms, Inotuzumab ozogamicin is a smart weapon that finds and attacks cancer cells while leaving healthy cells unharmed. It's like sending in a superhero to defeat the bad guys without causing harm to the innocent bystanders.
Have any queries, book a consultation with our Oncology Clinical Specialist
What is useful for?
Inotuzumab ozogamicin is useful for treating a type of blood cancer called acute lymphoblastic leukemia (ALL). This cancer affects white blood cells and can be challenging to treat. Inotuzumab ozogamicin specifically targets and attacks the cancer cells, helping to stop the cancer from spreading and improving the chances of survival for people with this condition.
Visit our Research Division Doctors in Online Consults for more details.
What if you miss the dose?
If you miss a dose of Inotuzumab ozogamicin, it's important to contact our healthcare provider right away. They can help you schedule your next dose and provide guidance on how to proceed. It's essential to stay on track with your treatment plan to get the best possible results. Missing a dose may affect how well the medication works against the cancer, so it's essential to follow our healthcare provider's instructions closely.
Please book a consultation with our Oncology Clinical Specialist to know more about what happens if you miss the dose.
Will there be Side Effects
Yes, there can be side effects when using Inotuzumab ozogamicin. Some common side effects may include nausea, fatigue, headache, fever, and low blood cell counts. More severe side effects may include liver problems, infusion-related reactions, and an increased risk of infection. It's essential to discuss any concerns about side effects with your healthcare provider, as they can provide guidance on managing them and ensuring your safety during treatment.
Have any queries, book a consultation with our Oncology Clinical Specialist
Tell us if you are taking other medicines like:-
If you are taking other medicines while using Inotuzumab ozogamicin, it's important to inform your healthcare provider. They can assess the potential for interactions between medications and provide guidance on the safest and most effective treatment plan for you. This ensures that all your medications work well together and helps prevent any harmful effects from drug interactions.
Have any queries, book a consultation with our Oncology Clinical Specialist
Safety Advice : Pregnancy, Liver or Kidney Damaged
Here's some simple safety advice about using Inotuzumab ozogamicin:
1. **Pregnancy:** If you are pregnant or planning to become pregnant, it's essential to discuss this with our healthcare provider before starting treatment with Inotuzumab ozogamicin. This medication may cause harm to an unborn baby, so it's crucial to use effective birth control during treatment and talk to our doctor about the risks and benefits.
2. **Liver or Kidney Problems:** If you have liver or kidney problems, it's important to let your healthcare provider know before starting treatment with Inotuzumab ozogamicin. They can assess your condition and determine if this medication is safe for you to use. In some cases, adjustments to the dosage or monitoring of liver and kidney function may be necessary during treatment.
By following these safety guidelines and discussing any concerns with your healthcare provider, you can ensure that treatment with Inotuzumab ozogamicin is safe and effective for you.
Have any queries, book a consultation with our Oncology Clinical Specialist
Pi Cancer Care
.png)
Copyright 2024 Reserved - Pi Cancer Care Clinic
77997 20123
Hyderabad
Home
Terms & Conditions
Privacy policy
Refund Policy